YOLFTbeta
Waverley Pharma Inc

Waverley Pharma Inc

WAVE · V · Healthcare / Biotechnology

0.02CAD+0.01 (+100.00%)

Price History

Full chart

Market Stats

Previous Close0.01
Open0.02
Day Range0.02 – 0.02
52-Week Range0.01 – 0.03
Volume6.00K
Market Cap540.00K
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta1.46
50-Day Avg0.014
200-Day Avg0.0169

About

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. In addition, it is involved in the sale of prescription medications, over-the-counter products, and associated pharmacy services. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Larry Thiessen M.B.A.
  • Employees0
  • Headquarters4-1250 Waverley Street, Winnipeg, MB, Canada, R3T 6C6, Canada
  • Websitehttps://www.waverleypharma.com

Leadership

  • Mr. Larry Thiessen M.B.A.President, CEO & Director
  • Mr. James F. Kinley C.A., CPAInterim CFO & Director · b. 1978

Financials

Income Statement

Currency: CAD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue000223.40K1.16M1.38M1.75M1.25M412.09K475.37K1.35M
Growth (%)----+418.03%+18.82%+27.47%-28.87%-66.95%+15.36%+183.90%
Cost of Revenue000190.64K1.11M1.19M1.53M963.04K332.29K261.33K835.92K
Gross Profit00032.76K48.94K181.71K222.67K283.79K79.80K214.04K513.68K
Gross Margin---14.66%4.23%13.21%12.70%22.76%19.36%45.03%38.06%
Operating Expense10.65K1.08K2.36M1.52M1.46M891.31K1.01M1.22M1.31M957.62K863.02K
Operating Income-10.65K-1.08K-2.36M-1.48M-1.41M-709.60K-786.83K-936.14K-1.23M-743.57K-349.34K
Operating Margin----664.60%-122.15%-51.60%-44.89%-75.08%-299.42%-156.42%-25.88%
EBITDA------701.43K-716.57K-724.04K-1.72M-656.13K-130.72K
EBITDA Margin------51.01%-40.88%-58.07%-417.59%-138.02%-9.69%
Net Income-10.65K-1.08K-2.36M-1.42M-1.21M-705.76K-796.51K-664.08K-2.22M-947.08K-499.21K
Net Income Margin----635.95%-104.97%-51.32%-45.44%-53.26%-539.70%-199.23%-36.99%
R&D10.33K91331.33K724.89K87.20K53.43K53.79K81.66K234.58K423.66K13.46K
R&D as % of Total Revenue---324.48%7.54%3.89%3.07%6.55%56.92%89.12%1.00%
Interest Expense0000000-76.90K162.54K179.20K
Interest Expense % of Total Revenue---0.00%0.00%0.00%0.00%-18.66%34.19%13.28%

Balance Sheet

Currency: CAD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1001006.66M5.24M4.39M3.49M3.68M2.69M952.29K2.05M1.24M
Total Liabilities10.65K11.72K1.60M1.26M1.55M1.45M1.89M1.60M2.09M4.08M3.82M
Total Equity-10.55K-11.62K5.06M3.97M2.85M2.04M1.79M1.09M-1.14M-2.03M-2.57M
Cash1001004.86M2.94M1.48M710.49K158.12K133.80K53.02K235.93K44.95K
Net Debt------104.24K567.93K1.55M2.57M3.18M

Cash Flow

Currency: CAD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-108.69K-108.69K-108.69K-1.45M-1.41M-361.70K-798.78K-237.06K-1.02M-410.19K-611.03K
Investing Cash Flow309.46K309.46K309.46K--------
Financing Cash Flow4.66M4.66M4.66M-488.80K-373.65K-373.65K222.36K439.37K940.33K1.20M376.71K
Capital Expenditure00000000000
Free Cash Flow---116.14K-1.45M-1.41M-361.70K-798.78K-237.06K-1.02M-410.19K-611.03K
FCF to OCF--106.86%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022May 25, 2023Aug 16, 2023Nov 25, 2026
EPS Estimate-5.81-5.60-------------------------
EPS Actual-7.63-6.23-0.04-0.05-0.01-0.01-0.00-0.00-0.00-0.00-0.01-0.01-0.00-0.000.00-0.01-0.00-0.00-0.00-0.01-0.01-0.00-0.00-0.00-0.01-0.00-
Surprise-31.33%-11.25%-------------------------
Timing------------------------After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap540.00K
Enterprise Value4.10M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.46
Price / Book1.91
EPS-0.01
Book Value-0.05
Revenue (TTM)1.17M
Gross Profit (TTM)393.10K
EBITDA-503.74K
Profit Margin-63.40%
Operating Margin-31.12%
Return on Equity-136.53%
Return on Assets-28.13%
Shares Outstanding54.00M
Shares Float13.55M
Beta1.46
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%